Skip to main content
Scholars@Duke
Menu
About
Schools / Institutes
Browse
Meenal Kapoor Kheterpal
Associate Professor of Dermatology
Dermatology
meenal.kheterpal@duke.edu
40 Duke Medicine Cir, Box 3135, Durham, NC 27710
40 Duke Medicine Cir, Durham, NC 27710
Research
More About This Person
glance {hide_children: true, active: false, enabled: true}
At a Glance
credentials {hide_children: true, active: false, enabled: true}
Credentials
Education
academic-experience {hide_children: true, active: false, enabled: true}
Academic Experience
Current Appointments & Affiliations
Previous Appointments & Affiliations
Leadership & Clinical Positions
expertise {hide_children: true, active: false, enabled: false}
Expertise
research {hide_children: false, active: true, enabled: true}
Research
Selected Grants
publications {hide_children: true, active: false, enabled: true}
Publications
Selected Publications
artistic-works {hide_children: true, active: false, enabled: false}
Artistic Works / Events
teaching {hide_children: true, active: false, enabled: false}
Teaching
advising-mentoring {hide_children: true, active: false, enabled: false}
Advising & Mentoring
recognition {hide_children: true, active: false, enabled: false}
Recognition
professional-activities {hide_children: true, active: false, enabled: false}
Professional Activities
Manage Profile
Embed Profile Data
Manage Profile
Embed Profile Data
Selected Grants
A Multicenter, Randomized, Double-blind, Vehicle-controlled, Phase 3 Efficacy and Safety Study of Patidegib Gel 2% for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Subjects with Gorlin Syndrome
Clinical Trial
Principal Investigator ·
Awarded by Sol-Gel Technologies Ltd. ·
2023 - 2026
To assess the safety and tolerability of single agent RP1 in selected organ transplant recipients
Clinical Trial
Principal Investigator ·
Awarded by Replimune Group, INC ·
2021 - 2025
A Phase 1 Study of Pre-Operative Cemiplimab (REGN2810), Administered Intralesionally, for Patients with Recurrent Cutaneous Squamous Cell Carcinoma (CSCC)
Clinical Trial
Principal Investigator ·
Awarded by Regeneron Pharmaceuticals, Inc. ·
2019 - 2025
An Open-Label Single-Arm Study of Dupilumab in Adolescent and Adult Skin of Color Patients with Moderate-to-Severe Atopic Dermatitis
Clinical Trial
Principal Investigator ·
Awarded by Regeneron Pharmaceuticals, Inc. ·
2023 - 2025
A Phase 2, Multi-Center Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients with Advanced Solid Tumors Harboring PTCH1 Loss ofFunction Mutations
Clinical Trial
Principal Investigator ·
Awarded by Endeavor BioMedicines, Inc. ·
2023 - 2024
A Study to Support Next Generation Sequencing Screening Process of Endeavor Studies in Patients with Advanced Solid Tumors
Clinical Trial
Principal Investigator ·
Awarded by Endeavor BioMedicines, Inc. ·
2023 - 2024
A MULTICENTER, PHASE 2B, RANDOMIZED, DOUBLE-BLIND, STRATIFIED, VEHICLE-CONTROLLED STUDY EVALUATING THE SAFETY AND EFFICACY OF SIROLIMUS 3.9% TOPICAL GEL IN PREVENTION OF BCCS IN PATIENTS WITH GORLIN SYNDROME
Clinical Trial
Principal Investigator ·
Awarded by Palvella Therapeutics, Inc ·
2021 - 2023
A Multicenter, Randomized, Double blind, Vehicle-controlled, Phase 2 Efficacy and Safety Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell C
Clinical Trial
Principal Investigator ·
Awarded by PellePharm ·
2020 - 2022
Pelle-926-301E: A Phase 3, Multicenter, Open-Label Extension Study of Patidegib Topical Gel, 2% in Subjects with Gorlin Syndrome (Basal Cell Nevus Syndrome)
Clinical Trial
Principal Investigator ·
Awarded by PellePharm ·
2020 - 2021
A Multicenter, Randomized, Double-blind, Vehicle-controlled, Phase 3 Efficacy and Safety Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell C
Clinical Trial
Principal Investigator ·
Awarded by PellePharm ·
2019 - 2021
Qualification of the Methodology to Identify and Measure Basal Cell Carcinomas (BCCs) on the face of patients with Basal Cell Nevus Syndrome (Gorlin Syndrome) or Sporadic BCCs
Research
Principal Investigator ·
Awarded by PellePharm ·
2018 - 2020
